The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Myxococcales


High impact information on Myxococcales


Chemical compound and disease context of Myxococcales


Biological context of Myxococcales


Gene context of Myxococcales

  • The fact that aromatic amino acids have been found to be the most representative of A-signal [Kuspa, A., Plamann, L. & Kaiser, D. (1992) J. Bacteriol. 174, 3319-3326] is consistent with the hypothesis that, regarding its specificity, MAP1 is likely to play a role in development of myxobacteria [16].
  • The sorangicins, novel and powerful inhibitors of eubacterial RNA polymerase isolated from myxobacteria [17].
  • Isolation, crystal and solution structure determination, and biosynthesis of tubulysins--powerful inhibitors of tubulin polymerization from myxobacteria [18].


  1. Heterologous expression of epothilone biosynthetic genes in Myxococcus xanthus. Julien, B., Shah, S. Antimicrob. Agents Chemother. (2002) [Pubmed]
  2. Mutation to acriflavine resistance in some myxobacteria. Grimm, K. Microbios (1980) [Pubmed]
  3. The chondramides: cytostatic agents from myxobacteria acting on the actin cytoskeleton. Sasse, F., Kunze, B., Gronewold, T.M., Reichenbach, H. J. Natl. Cancer Inst. (1998) [Pubmed]
  4. Steroid biosynthesis in prokaryotes: identification of myxobacterial steroids and cloning of the first bacterial 2,3(S)-oxidosqualene cyclase from the myxobacterium Stigmatella aurantiaca. Bode, H.B., Zeggel, B., Silakowski, B., Wenzel, S.C., Reichenbach, H., Müller, R. Mol. Microbiol. (2003) [Pubmed]
  5. Antifungal agents. 4. Chemical modification of antibiotics from Polyangium cellulosum var. fulvum. Ester and amide analogues of ambruticin. Connor, D.T., von Strandtmann, M. J. Med. Chem. (1979) [Pubmed]
  6. The Stigmatella aurantiaca homolog of Myxococcus xanthus high-mobility-group A-type transcription factor CarD: insights into the functional modules of CarD and their distribution in bacteria. Cayuela, M.L., Elías-Arnanz, M., Peñalver-Mellado, M., Padmanabhan, S., Murillo, F.J. J. Bacteriol. (2003) [Pubmed]
  7. Characterization and description of Anaeromyxobacter dehalogenans gen. nov., sp. nov., an aryl-halorespiring facultative anaerobic myxobacterium. Sanford, R.A., Cole, J.R., Tiedje, J.M. Appl. Environ. Microbiol. (2002) [Pubmed]
  8. Iso-branched 2- and 3-hydroxy fatty acids as characteristic lipid constituents of some gliding bacteria. Fautz, E., Rosenfelder, G., Grotjahn, L. J. Bacteriol. (1979) [Pubmed]
  9. Comparison of spontaneous, UV-induced, and nitrosoguanidine-induced mutability to drug resistance in myxobacteria. Grimm, K. J. Bacteriol. (1978) [Pubmed]
  10. A biosynthetic pathway to isovaleryl-CoA in myxobacteria: the involvement of the mevalonate pathway. Mahmud, T., Wenzel, S.C., Wan, E., Wen, K.W., Bode, H.B., Gaitatzis, N., Müller, R. Chembiochem (2005) [Pubmed]
  11. Enhygromyxa salina gen. nov., sp. nov., a slightly halophilic myxobacterium isolated from the coastal areas of Japan. Iizuka, T., Jojima, Y., Fudou, R., Tokura, M., Hiraishi, A., Yamanaka, S. Syst. Appl. Microbiol. (2003) [Pubmed]
  12. The myxochelin iron transport regulon of the myxobacterium Stigmatella aurantiaca Sg a15. Silakowski, B., Kunze, B., Nordsiek, G., Blöcker, H., Höfle, G., Müller, R. Eur. J. Biochem. (2000) [Pubmed]
  13. Determination of bacterial ammonia pools using Myxococcus virescens as an example. Gerth, K., Reichenbach, H. Anal. Biochem. (1986) [Pubmed]
  14. Crocacin, a new electron transport inhibitor from Chondromyces crocatus (myxobacteria). Production, isolation, physico-chemical and biological properties. Kunze, B., Jansen, R., Höfle, G., Reichenbach, H. J. Antibiot. (1994) [Pubmed]
  15. Haliangium ochraceum gen. nov., sp. nov. and Haliangium tepidum sp. nov.: novel moderately halophilic myxobacteria isolated from coastal saline environments. Fudou, R., Jojima, Y., Iizuka, T., Yamanaka, S. J. Gen. Appl. Microbiol. (2002) [Pubmed]
  16. Purification and characterization of an alkaline elastase from Myxococcus xanthus. Dumont, L., Verneuil, B., Wallach, J., Julien, R. Eur. J. Biochem. (1994) [Pubmed]
  17. The sorangicins, novel and powerful inhibitors of eubacterial RNA polymerase isolated from myxobacteria. Irschik, H., Jansen, R., Gerth, K., Höfle, G., Reichenbach, H. J. Antibiot. (1987) [Pubmed]
  18. Isolation, crystal and solution structure determination, and biosynthesis of tubulysins--powerful inhibitors of tubulin polymerization from myxobacteria. Steinmetz, H., Glaser, N., Herdtweck, E., Sasse, F., Reichenbach, H., Höfle, G. Angew. Chem. Int. Ed. Engl. (2004) [Pubmed]
WikiGenes - Universities